Literature DB >> 21588750

1,2,3,4-Tetra-hydro-phenazine 5,10-dioxide.

Tao Sun, Jianye Li, Hongwei Qiao, Aiyou Hao, Yueming Li.   

Abstract

The complete mol-ecule of the title compound, C(12)H(12)N(2)O(2), lies on two crystallographic symmetry elements: a twofold axis and a mirror plane. In the mol-ecular structure, the n class="Chemical">quinoxaline ring and two methyl-ene substituents lie on the mirror plane while the other two methyl-ene groups are disordered about the plane. The crystal packing is stabilized by weak inter-molecular π-π stacking inter-actions with centroid-centroid distances of 3.6803 (7) Å.

Entities:  

Year:  2010        PMID: 21588750      PMCID: PMC3008063          DOI: 10.1107/S1600536810030242

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the synthetic preparation, see: Haddadin & Issidorides (1965 ▶); Issidorides & Haddadin (1966 ▶). For background to quinoxaline di-N-oxide compounds, see: Edwards et al. (1975 ▶) and for their biological activity, see: Urquiola et al. (2008 ▶). For a related structure, see: Wang et al. (2010 ▶).

Experimental

Crystal data

C12H12N2O2 M = 216.24 Orthorhombic, a = 11.7780 (2) Å b = 13.1938 (3) Å c = 6.5561 (1) Å V = 1018.80 (3) Å3 Z = 4 Mo Kα radiation μ = 0.10 mm−1 T = 296 K 0.31 × 0.29 × 0.26 mm

Data collection

Bruker APEXII CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 1996 ▶) T min = 0.67, T max = 0.74 3311 measured reflections 620 independent reflections 534 reflections with I > 2σ(I) R int = 0.016

Refinement

R[F 2 > 2σ(F 2)] = 0.040 wR(F 2) = 0.127 S = 1.10 620 reflections 61 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.23 e Å−3 Δρmin = −0.29 e Å−3 Data collection: APEX2 (Bruker, 2007 ▶); cell refinement: SAINT (Bruker, 2007 ▶); data reduction: SAINT; program(s) used to solve structure: SIR97 (Altomare et al., 1999 ▶); program(s) used to refine structure: SHELXTL (Sheldrick, 2008 ▶); molecular graphics: SHELXTL; software used to prepare material for publication: WinGX (Farrugia, 1999 ▶). Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536810030242/nk2042sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810030242/nk2042Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C12H12N2O2F(000) = 456
Mr = 216.24Dx = 1.410 Mg m3
Orthorhombic, CmcmMo Kα radiation, λ = 0.71073 Å
Hall symbol: -C 2c 2Cell parameters from 1577 reflections
a = 11.7780 (2) Åθ = 2.3–26.8°
b = 13.1938 (3) ŵ = 0.10 mm1
c = 6.5561 (1) ÅT = 296 K
V = 1018.80 (3) Å3Prism, yellow
Z = 40.31 × 0.29 × 0.26 mm
Bruker APEXII CCD area-detector diffractometer620 independent reflections
Radiation source: fine-focus sealed tube534 reflections with I > 2σ(I)
graphiteRint = 0.016
φ and ω scansθmax = 26.9°, θmin = 2.3°
Absorption correction: multi-scan (SADABS; Sheldrick, 1996)h = −14→14
Tmin = 0.67, Tmax = 0.74k = −16→12
3311 measured reflectionsl = −8→8
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.040Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.127H atoms treated by a mixture of independent and constrained refinement
S = 1.10w = 1/[σ2(Fo2) + (0.0854P)2 + 0.1004P] where P = (Fo2 + 2Fc2)/3
620 reflections(Δ/σ)max < 0.001
61 parametersΔρmax = 0.23 e Å3
0 restraintsΔρmin = −0.29 e Å3
Experimental. 1H NMR (400?MHz, DMSO-d6): δ 8.67 (2H, d, J = 3.5?Hz, Ar—H), 7.89 (2H, d, J = 3.2?Hz, Ar—H), 3.77 (1H, s, CH), 2.66 (3H, s, CH3), 2.51 (2H, m, CH2), 1.45 (6H, s, CH3); Calcd for C13H16N2O2: C, 67.22; H, 6.94; N, 12.06. Found: C, 67.18; H, 6.99; N, 11.95; ESIMS calcd for C13H16N2O2H+ m/z 232.38, found m/z 232.19.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/UeqOcc. (<1)
C10.44078 (13)−0.14330 (10)0.25000.0434 (4)
H10.4017−0.20450.25000.052*
C20.38142 (12)−0.05388 (9)0.25000.0399 (4)
H20.3025−0.05440.25000.048*
C30.44062 (11)0.03818 (9)0.25000.0311 (4)
C40.44068 (10)0.21722 (9)0.25000.0326 (4)
C50.37292 (12)0.31337 (10)0.25000.0470 (4)
H50.3247 (10)0.3113 (9)0.131 (2)0.070*
C60.44666 (19)0.40485 (17)0.1867 (4)0.0618 (9)0.50
H60.407 (2)0.4669 (19)0.199 (5)0.090*0.50
H70.468 (3)0.3993 (19)0.040 (4)0.090*0.50
N10.38161 (10)0.12976 (7)0.25000.0336 (4)
O10.27161 (9)0.12938 (6)0.25000.0508 (4)
U11U22U33U12U13U23
C10.0608 (9)0.0288 (7)0.0407 (7)−0.0082 (5)0.0000.000
C20.0426 (8)0.0339 (7)0.0432 (7)−0.0078 (5)0.0000.000
C30.0339 (8)0.0281 (7)0.0314 (6)−0.0008 (4)0.0000.000
C40.0318 (7)0.0277 (7)0.0384 (7)0.0008 (4)0.0000.000
C50.0372 (8)0.0320 (8)0.0719 (10)0.0056 (5)0.0000.000
C60.0516 (11)0.0289 (10)0.105 (3)0.0038 (7)0.0002 (10)0.0110 (10)
N10.0282 (6)0.0313 (6)0.0412 (6)−0.0005 (3)0.0000.000
O10.0269 (6)0.0447 (7)0.0807 (8)−0.0011 (3)0.0000.000
C1—C21.3714 (19)C5—C6ii1.544 (3)
C1—C1i1.395 (3)C5—C61.544 (3)
C1—H10.9300C5—H50.965 (13)
C2—C31.4005 (17)C6—C6ii0.831 (5)
C2—H20.9300C6—C6iii1.256 (5)
C3—N11.3939 (15)C6—C6i1.506 (4)
C3—C3i1.399 (2)C6—H60.95 (2)
C4—N11.3474 (15)C6—H71.00 (3)
C4—C4i1.397 (2)N1—O11.2956 (16)
C4—C51.4987 (16)
C2—C1—C1i120.65 (9)C6ii—C6—C6iii90.000 (2)
C2—C1—H1119.7C6ii—C6—C6i56.5 (2)
C1i—C1—H1119.7C6iii—C6—C6i33.5 (2)
C1—C2—C3119.49 (15)C6ii—C6—C574.39 (10)
C1—C2—H2120.3C6iii—C6—C5124.23 (10)
C3—C2—H2120.3C6i—C6—C5108.72 (16)
N1—C3—C3i119.90 (7)C6ii—C6—H685.1 (18)
N1—C3—C2120.24 (14)C6iii—C6—H6119.6 (16)
C3i—C3—C2119.86 (8)C6i—C6—H6111.4 (17)
N1—C4—C4i121.08 (7)C5—C6—H6112.1 (16)
N1—C4—C5116.74 (12)C6ii—C6—H7164.4 (18)
C4i—C4—C5122.17 (7)C6iii—C6—H775.0 (18)
C4—C5—C6ii111.23 (14)C6i—C6—H7108.4 (18)
C4—C5—C6111.23 (14)C5—C6—H7110.3 (16)
C6ii—C5—C631.2 (2)H6—C6—H7106 (2)
C4—C5—H5106.8 (7)O1—N1—C4121.31 (9)
C6ii—C5—H5124.8 (8)O1—N1—C3119.68 (9)
C6—C5—H597.8 (7)C4—N1—C3119.01 (13)
C1i—C1—C2—C30.0C4—C5—C6—C6i−50.6 (2)
C1—C2—C3—N1180.0C6ii—C5—C6—C6i45.6 (2)
C1—C2—C3—C3i0.0C4i—C4—N1—O1180.0
N1—C4—C5—C6ii163.23 (11)C5—C4—N1—O10.0
C4i—C4—C5—C6ii−16.77 (11)C4i—C4—N1—C30.0
N1—C4—C5—C6−163.23 (11)C5—C4—N1—C3180.0
C4i—C4—C5—C616.77 (11)C3i—C3—N1—O1180.0
C4—C5—C6—C6ii−96.23 (6)C2—C3—N1—O10.0
C4—C5—C6—C6iii−17.19 (11)C3i—C3—N1—C40.0
C6ii—C5—C6—C6iii79.04 (8)C2—C3—N1—C4180.0
  4 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  3-Substituted 2-formylquinoxaline 1,4-dioxides.

Authors:  M L Edwards; R E Bambury; H W Ritter
Journal:  J Med Chem       Date:  1975-06       Impact factor: 7.446

3.  New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.

Authors:  Carolina Urquiola; Dinorah Gambino; Mauricio Cabrera; María Laura Lavaggi; Hugo Cerecetto; Mercedes González; Adela López de Cerain; Antonio Monge; Antonio J Costa-Filho; María H Torre
Journal:  J Inorg Biochem       Date:  2007-08-01       Impact factor: 4.155

4.  2-(4-Bromo-phen-yl)quinoxaline.

Authors:  Zhi-Jian Wang; Wei-Min Jia; Hong-Guo Yao; Hong Qiu; Wei Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.